• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

致编辑的信：“循环游离DNA和循环肿瘤细胞作为一线化疗的晚期非小细胞肺癌患者的预后和预测生物标志物”

Letter to the Editor: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".

作者信息

Nicolazzo Chiara, Raimondi Cristina, Loreni Flavia, Gazzaniga Paola, Gradilone Angela

机构信息

Circulating Tumor Cells Unit, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.

出版信息

Int J Mol Sci. 2017 Jun 19;18(6):1308. doi: 10.3390/ijms18061308.

DOI:10.3390/ijms18061308
PMID:28629196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5486129/
Abstract

n/a.

摘要

无可用信息。

相似文献

1
Letter to the Editor: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".致编辑的信：“循环游离DNA和循环肿瘤细胞作为一线化疗的晚期非小细胞肺癌患者的预后和预测生物标志物”
Int J Mol Sci. 2017 Jun 19;18(6):1308. doi: 10.3390/ijms18061308.
2
Reply to the Letter to the Editor by C. Nicolazzo et al.: "Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy".对C. Nicolazzo等人致编辑信的回复：“循环游离DNA和循环肿瘤细胞作为一线化疗的晚期非小细胞肺癌患者的预后和预测生物标志物”
Int J Mol Sci. 2017 Jun 19;18(6):1309. doi: 10.3390/ijms18061309.
3
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.循环游离DNA和循环肿瘤细胞作为一线化疗的晚期非小细胞肺癌患者的预后和预测生物标志物
Int J Mol Sci. 2017 May 11;18(5):1035. doi: 10.3390/ijms18051035.
4
Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.循环游离核酸和血小板作为液体活检在肺癌患者个性化治疗中的应用
Lung Cancer. 2017 May;107:100-107. doi: 10.1016/j.lungcan.2016.04.026. Epub 2016 May 4.
5
Circulating Biomarkers in Non-Small-Cell Lung Cancer: Current Status and Future Challenges.非小细胞肺癌中的循环生物标志物：现状与未来挑战
Clin Lung Cancer. 2016 Nov;17(6):507-516. doi: 10.1016/j.cllc.2016.05.021. Epub 2016 Jun 8.
6
Possible applications of circulating tumor cells in patients with non small cell lung cancer.循环肿瘤细胞在非小细胞肺癌患者中的潜在应用。
Lung Cancer. 2017 May;107:59-64. doi: 10.1016/j.lungcan.2016.05.027. Epub 2016 May 31.
7
Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.接受卡铂和紫杉醇治疗的非小细胞肺癌患者的循环内皮细胞
J Thorac Oncol. 2009 Feb;4(2):208-13. doi: 10.1097/JTO.0b013e318193030d.
8
[Research progress of circulating tumor DNA methylation in non-small cell lung cancer].非小细胞肺癌中循环肿瘤DNA甲基化的研究进展
Zhonghua Jie He He Hu Xi Za Zhi. 2018 Dec 12;41(12):967-970. doi: 10.3760/cma.j.issn.1001-0939.2018.12.013.
9
Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma.BRAF 突变型肺腺癌中循环肿瘤细胞和循环肿瘤 DNA 中 BRAF 突变的检测与监测
J Thorac Oncol. 2016 Sep;11(9):e109-12. doi: 10.1016/j.jtho.2016.05.001. Epub 2016 May 7.
10
Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages.液体活检在非小细胞肺癌从早期到晚期的当前和未来应用。
Eur Respir Rev. 2020 Feb 12;29(155). doi: 10.1183/16000617.0052-2019. Print 2020 Mar 31.

本文引用的文献

1
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system非小细胞肺癌患者循环肿瘤细胞中的程序性死亡受体配体1（PD-L1）与上皮-间质转化：一种逃避免疫系统的分子屏障
Oncoimmunology. 2017 Apr 20;6(12):e1315488. doi: 10.1080/2162402X.2017.1315488. eCollection 2017.
2
EpCAM-expressing circulating tumor cells in colorectal cancer.表达上皮细胞黏附分子的结直肠癌循环肿瘤细胞
Int J Biol Markers. 2017 Oct 31;32(4):e415-e420. doi: 10.5301/ijbm.5000284.
3
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.循环游离DNA和循环肿瘤细胞作为一线化疗的晚期非小细胞肺癌患者的预后和预测生物标志物
Int J Mol Sci. 2017 May 11;18(5):1035. doi: 10.3390/ijms18051035.
4
Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine.多西他赛和吉西他滨治疗的晚期非小细胞肺癌患者循环肿瘤细胞的预后意义
Clin Transl Oncol. 2014 Jul;16(7):637-43. doi: 10.1007/s12094-013-1128-8. Epub 2013 Nov 12.
5
Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?形态学标准是否足以鉴定肾癌中的循环肿瘤细胞？
J Transl Med. 2013 Sep 17;11:214. doi: 10.1186/1479-5876-11-214.